Subject(s)
Basilar Artery/surgery , Cerebral Infarction/surgery , Oculomotor Nerve Diseases/surgery , Stents , Vestibular Diseases/surgery , Aged , Angiography, Digital Subtraction , Cerebral Infarction/complications , Cerebral Infarction/pathology , Diffusion Magnetic Resonance Imaging , Female , Gait Disorders, Neurologic/etiology , Humans , Magnetic Resonance Imaging , Neurosurgical Procedures , Nystagmus, Pathologic/etiology , Oculomotor Nerve Diseases/etiology , Oculomotor Nerve Diseases/pathology , Reflex, Vestibulo-Ocular/physiology , Stroke/etiology , Supine Position/physiology , Vestibular Diseases/etiology , Vestibular Diseases/pathologyABSTRACT
OPINION STATEMENT: Malignant middle cerebral artery (MCA) infarction occurs in about 10% of all patients with supratentorial ischemic strokes. The infarction involves the entire MCA territory. Due to the consequences of severe brain edema, brain herniation, elevated intracranial pressure (ICP), and midline shift, these events carry a mortality rate of up to 80%. No clinical trials have been conducted to study the efficacy of the osmotic agents such as mannitol or hypertonic saline. Furthermore, aggressive use of such treatments may be detrimental. Surgical decompression has previously been proposed as a way to relieve the vicious cycle of malignant cerebral edema and reduced cerebral perfusion. Its use in relieving ICP is also controversial. Recently, a pooled analysis of three independent European trials has shown that decompressive hemicraniectomy is clearly beneficial in reducing mortality from large hemispheric infarctions. Although controversies still exist on its indications, surgical decompression can effectively reduce ICP, reduce mortality, and improve neurologic outcomes in selected patients with a malignant MCA stroke syndrome.
ABSTRACT
Cerebral venous sinus thrombosis (CVST) is an uncommon condition with severe consequences. Although we do not know the exact incidence and prevalence of CVST, it is an important diagnosis. Over the past decade, it has been diagnosed more frequently due to greater awareness and availability of noninvasive diagnostic techniques. Furthermore, routine diagnostic neuroimaging has been used to monitor the clinical progress of these patients, especially in deteriorating cases. In order to decrease morbidity and mortality, an understanding of CVST treatment options is important. Treatment of extensive intracranial venous sinus thrombosis with intrasinus infusion of recombinant tissue plasminogen activator (rt-PA) is relatively controversial as there are no clear guidelines in regards to appropriate therapeutic management. We report a case of successful intrasinus thrombolysis of deep cerebral sinus thrombosis (DCST) resulting in rapid radiographic improvement associated with complete clinical recovery.
ABSTRACT
BACKGROUND AND PURPOSE: Acute vestibular syndrome (AVS) is often due to vestibular neuritis but can result from vertebrobasilar strokes. Misdiagnosis of posterior fossa infarcts in emergency care settings is frequent. Bedside oculomotor findings may reliably identify stroke in AVS, but prospective studies have been lacking. METHODS: The authors conducted a prospective, cross-sectional study at an academic hospital. Consecutive patients with AVS (vertigo, nystagmus, nausea/vomiting, head-motion intolerance, unsteady gait) with >or=1 stroke risk factor underwent structured examination, including horizontal head impulse test of vestibulo-ocular reflex function, observation of nystagmus in different gaze positions, and prism cross-cover test of ocular alignment. All underwent neuroimaging and admission (generally <72 hours after symptom onset). Strokes were diagnosed by MRI or CT. Peripheral lesions were diagnosed by normal MRI and clinical follow-up. RESULTS: One hundred one high-risk patients with AVS included 25 peripheral and 76 central lesions (69 ischemic strokes, 4 hemorrhages, 3 other). The presence of normal horizontal head impulse test, direction-changing nystagmus in eccentric gaze, or skew deviation (vertical ocular misalignment) was 100% sensitive and 96% specific for stroke. Skew was present in 17% and associated with brainstem lesions (4% peripheral, 4% pure cerebellar, 30% brainstem involvement; chi(2), P=0.003). Skew correctly predicted lateral pontine stroke in 2 of 3 cases in which an abnormal horizontal head impulse test erroneously suggested peripheral localization. Initial MRI diffusion-weighted imaging was falsely negative in 12% (all <48 hours after symptom onset). CONCLUSIONS: Skew predicts brainstem involvement in AVS and can identify stroke when an abnormal horizontal head impulse test falsely suggests a peripheral lesion. A 3-step bedside oculomotor examination (HINTS: Head-Impulse-Nystagmus-Test-of-Skew) appears more sensitive for stroke than early MRI in AVS.
Subject(s)
Diffusion Magnetic Resonance Imaging/standards , Nystagmus, Pathologic/diagnosis , Point-of-Care Systems/standards , Stroke/diagnosis , Vertigo/diagnosis , Acute Disease , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Nausea/diagnosis , Nausea/physiopathology , Nystagmus, Pathologic/physiopathology , Prospective Studies , Reflex, Vestibulo-Ocular/physiology , Stroke/physiopathology , Syndrome , Time Factors , Vertigo/physiopathology , Vomiting/diagnosis , Vomiting/physiopathologyABSTRACT
Intracerebral hemorrhage (ICH) is the most lethal type of stroke. Level I, class A evidence of effective treatment is lacking. Many issues surrounding the optimal management of ICH, such as blood pressure control, prevention of hematoma growth, containing brain edema, and preserving cerebral perfusion, need more rigorous clinical research. However, when selected appropriately, the mortality of certain patients with ICH may improve when treated early with minimally invasive neurosurgery or perhaps intravenous hemostatics. In addition, patients with ICHs may have better outcome when medical care is optimized according to the published ICH treatment guidelines. Stem cell therapy has shown promise for better functional recovery.
Subject(s)
Cerebral Hemorrhage/therapy , Blood Pressure , Cerebral Hemorrhage/etiology , Cerebral Hemorrhage/pathology , Cerebrovascular Circulation/physiology , Hematoma/pathology , Humans , Hypertension/complications , Magnetic Resonance Imaging , Neuroprotective Agents/therapeutic use , Randomized Controlled Trials as Topic , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
BACKGROUND AND PURPOSE: Historically, the use of tissue plasminogen activator (tPA) thrombolysis in pregnancy has been regarded as relatively contraindicated. Underlying this stance has been the concern over the risk of bleeding complications in both mother and child. SUMMARY OF CASE: We report the successful use of intravenous recombinant tPA (rtPA) thrombolysis in a pregnant woman with acute cardioembolic stroke. CONCLUSIONS: The patient improved clinically, did not develop complications after receiving rtPA, and at 37 weeks' gestation, delivered a healthy infant, demonstrating that rtPA thrombolysis may be used safely in pregnant women.